Interplay between MASLD, obesity and type 2 diabetes: epidemiology, shared pathways and clinical implications - Quiz - MDSpire

Interplay between MASLD, obesity and type 2 diabetes: epidemiology, shared pathways and clinical implications

  • By

  • Kenneth Tachi

  • Adwoa Agyei-Nkansah

  • Yacoba Atiase

  • Bright Forkuo

  • Victoria Akosua Agyen-Frimpong

  • July 2, 2026

  • 0 min

Share

Original Source(s)

Interplay between MASLD, obesity and type 2 diabetes: epidemiology, shared pathways and clinical implications

  • by Kenneth Tachi, Adwoa Agyei-Nkansah, Yacoba Atiase, Bright Forkuo, Victoria Akosua Agyen-Frimpong

  • July 2, 2026

Related Content

Accuracy of splenic stiffness measurement for predicting clinically significant varices in children with portal hypertension: a systematic review and diagnostic test accuracy meta-analysis

The liver-brain axis, from its function to preventive therapeutic strategies in diseases

Hepatic Steatosis Severity Prediction in Nonobese Individuals: Machine Learning Model Development and Validation